The effects of early conversion from calcineurin inhibitors to Rapamune [sirolimus] on the development of chronic allograft nephropathy compared to unit protocol (conversion to mycophenolate mofetil)

Trial Profile

The effects of early conversion from calcineurin inhibitors to Rapamune [sirolimus] on the development of chronic allograft nephropathy compared to unit protocol (conversion to mycophenolate mofetil)

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 22 Jul 2005

At a glance

  • Drugs Sirolimus (Primary) ; Mycophenolate mofetil
  • Indications Renal transplant rejection
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Jul 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top